Clinical trial NCT00557011 - References

Attention Deficit Disorder With Hyperactivity — NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD

Citation(s)

•   Biederman J, Boellner SW, Childress A, Lopez FA, Krishnan S, Zhang Y
  Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study. Biol Psychiatry. 20

A Phase 2, Randomized, Double-Blind, Placebo- and Active-Controlled, 3-Treatment, 3-Period, Crossover Study With One Week Per Treatment and Once-a-Day Dosing of Either NRP104, Adderall XR, or Placebo in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD)

Details for clinical trial NCT00557011